Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Richard Owen Mannion"'
Autor:
Angelica Dorantes, Vinod P. Shah, Richard Owen Mannion, Patrick K. Noonan, Colleen Ruegger, Glenn A. Van Buskirk, Bruce Thompson, Ryan MacKenzie, Satish Asotra, Matthew Howard, Theresa Henry, Satyam Upadrashta, Christopher Balducci, Tapash Ghosh, Richard P. Poska, Ramani R. Raghavan, Terrance Ocheltree, Eric Sanchez, Prabir K. Basu, Jason Kamm, Gerald C. DiDonato, Mario A. Gonzalez, Michael L. Putnam, Steven Laurenz, Umesh Pai, Russell Somma, Avinash G. Thombre, Robert Joseph Timko, W. Mark Eickhoff, Vijay Tammara, Sivakumar Vaithiyalingam, Zezhi Jesse Shao
Publikováno v:
AAPS PharmSciTech
In this whitepaper, the Manufacturing Technical Committee of the Product Quality Research Institute provides information on the common, best practices in use today in the development of high-quality chemistry, manufacturing and controls documentation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05d3847ff11819526e4784ee995335d0
https://doi.org/10.1208/s12249-014-0087-x
https://doi.org/10.1208/s12249-014-0087-x
Autor:
Richard Owen Mannion, J. David Haddox
Publikováno v:
Pain. 157(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::482f14be948c1a193f5472d1745d66d9
https://pubmed.ncbi.nlm.nih.gov/27841841
https://pubmed.ncbi.nlm.nih.gov/27841841
Autor:
Jennifer Giordano, James Cassidy, Aeri Park, Manjunath S. Shet, Edward Patrick O'donnell, Daniel P. McNamara, Anthony Iarriccio, Richard Owen Mannion, Scott L. Childs
Publikováno v:
Pharmaceutical Research. 23:1888-1897
The bioavailability of a development candidate active pharmaceutical ingredient (API) was very low after oral dosing in dogs. In order to improve bioavailability, we sought to increase the dissolution rate of the solid form of the API. When tradition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf66ed019040f96c52bce2dca517f6c5
https://doi.org/10.1007/s11095-006-9032-3
https://doi.org/10.1007/s11095-006-9032-3
Autor:
Gary L. Stiles, Richard Owen Mannion, Brianne Weingarten, Louis Alexander, Richard J. Fanelli
Publikováno v:
Drug and alcohol dependence. 138
Background Millions of patients are treated with opioid analgesics (OpAs) to relieve pain. Unfortunately, these medications are subject to abuse and/or unintended misuse. Abuse deterrent formulations (ADFs) represent an intervention strategy to decre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3792e72f71e4fd9869e06ce7d3ae2cf9
https://pubmed.ncbi.nlm.nih.gov/24613631
https://pubmed.ncbi.nlm.nih.gov/24613631